Novartis engages in the clinical research, development, and scaled manufacturing of innovative medicines. The drug pipeline is concentrated in medical areas such as cardiovascular, immunology, neuroscience, and solid tumors. The company operates molecular screening laboratories and biological manufacturing facilities, advancing the clinical safety and efficacy testing of drug candidates. Approved medications are primarily sold in bulk to hospitals, specialty clinics, and government medical procurement departments across multiple countries.